-
T288817-25mgPotent MAP4K2 (GCK) inhibitor.
-
T288817-50mgPotent MAP4K2 (GCK) inhibitor.
-
T288817-5mgPotent MAP4K2 (GCK) inhibitor.
-
T288148-100mgTLQP 21 TFA.
-
-
-
-
C288437-100mgApplicationTLR4-IN-C34 has been used as an inhibitor in the HFD-feeding mice to verify the aforementioned in vitro pathway (stearic acid/LDH-a/cytokines) in vivo.
-
C288437-10mgApplicationTLR4-IN-C34 has been used as an inhibitor in the HFD-feeding mice to verify the aforementioned in vitro pathway (stearic acid/LDH-a/cytokines) in vivo.
-
C288437-25mgApplicationTLR4-IN-C34 has been used as an inhibitor in the HFD-feeding mice to verify the aforementioned in vitro pathway (stearic acid/LDH-a/cytokines) in vivo.
-
C288437-50mgApplicationTLR4-IN-C34 has been used as an inhibitor in the HFD-feeding mice to verify the aforementioned in vitro pathway (stearic acid/LDH-a/cytokines) in vivo.
-
C288437-5mgApplicationTLR4-IN-C34 has been used as an inhibitor in the HFD-feeding mice to verify the aforementioned in vitro pathway (stearic acid/LDH-a/cytokines) in vivo.